SE7706526L - Forfarande for framstellnilng av 3-(3-karboxi-4-hydroxifenyl)-4,5-dihydro-2-fenylbens/e/indol och dermed beslektade verdefulla mellanforeningar - Google Patents

Forfarande for framstellnilng av 3-(3-karboxi-4-hydroxifenyl)-4,5-dihydro-2-fenylbens/e/indol och dermed beslektade verdefulla mellanforeningar

Info

Publication number
SE7706526L
SE7706526L SE7706526A SE7706526A SE7706526L SE 7706526 L SE7706526 L SE 7706526L SE 7706526 A SE7706526 A SE 7706526A SE 7706526 A SE7706526 A SE 7706526A SE 7706526 L SE7706526 L SE 7706526L
Authority
SE
Sweden
Prior art keywords
phenylbenz
indol
hydroxyphenyl
dihydro
carboxy
Prior art date
Application number
SE7706526A
Other languages
English (en)
Other versions
SE425391B (sv
Inventor
R C Effland
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7706526L publication Critical patent/SE7706526L/sv
Publication of SE425391B publication Critical patent/SE425391B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE7706526A 1976-06-03 1977-06-03 Forfarande for framstellning av 3-(3-karboxi-4-hydroxifenyl)-4,5-dihydro-2-fenylbens /e/ indol med verdefulla terapeutiska egenskaper SE425391B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/692,331 US4066659A (en) 1976-06-03 1976-06-03 Method of preparation of 3-(3-carboxy-4-hydroxyphenyl)-4,5-dihydro-2-phenylbenz (e) indole and valuable intermediates related thereto

Publications (2)

Publication Number Publication Date
SE7706526L true SE7706526L (sv) 1977-12-04
SE425391B SE425391B (sv) 1982-09-27

Family

ID=24780138

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7706526A SE425391B (sv) 1976-06-03 1977-06-03 Forfarande for framstellning av 3-(3-karboxi-4-hydroxifenyl)-4,5-dihydro-2-fenylbens /e/ indol med verdefulla terapeutiska egenskaper

Country Status (14)

Country Link
US (1) US4066659A (sv)
JP (1) JPS5325556A (sv)
AT (1) AT353786B (sv)
BE (1) BE855406A (sv)
CA (1) CA1105936A (sv)
CH (1) CH629774A5 (sv)
DE (1) DE2724601A1 (sv)
DK (1) DK145296C (sv)
ES (1) ES459256A1 (sv)
FI (1) FI65059C (sv)
HU (1) HU176801B (sv)
IT (1) IT1076781B (sv)
NL (1) NL7705807A (sv)
SE (1) SE425391B (sv)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356431A (en) * 1971-06-03 1974-06-12 Wyeth John & Brother Ltd Substituted benz-g-indoles
US3931407A (en) * 1973-03-01 1976-01-06 American Hoechst Corporation Method of treatment with and compositions containing condensed pyrroles bearing an N-phenyl substituent

Also Published As

Publication number Publication date
DE2724601C2 (sv) 1988-03-03
DK243677A (da) 1977-12-04
JPS6120546B2 (sv) 1986-05-22
DE2724601A1 (de) 1977-12-22
DK145296C (da) 1983-03-14
CH629774A5 (de) 1982-05-14
JPS5325556A (en) 1978-03-09
AT353786B (de) 1979-12-10
ES459256A1 (es) 1978-03-01
DK145296B (da) 1982-10-25
ATA392877A (de) 1979-05-15
HU176801B (en) 1981-05-28
FI65059C (fi) 1984-03-12
SE425391B (sv) 1982-09-27
FI771747A (sv) 1977-12-04
BE855406A (fr) 1977-12-05
US4066659A (en) 1978-01-03
FI65059B (fi) 1983-11-30
NL7705807A (nl) 1977-12-06
IT1076781B (it) 1985-04-27
CA1105936A (en) 1981-07-28

Similar Documents

Publication Publication Date Title
ES2147646T3 (es) Composiciones para diagnostico, prevencion y tratamiento de la progresion de los tumores.
NO20030211D0 (no) Blandinger og fremgangsmåter for terapi og diagnose av ovariekreft
DE3689363T2 (de) Pharmazeutische Zusammensetzungen zur Behandlung der Metastasen von Krebstumoren.
ES2134294T3 (es) Reactividad inmune para oncogenes expresados activos para la diagnosis y el tratamiento de tumores malignos.
SE7600563L (sv) Forfarande for framstellning av antracyklinoner
NZ512247A (en) Compositions and methods for therapy and diagnosis of ovarian cancer
DK0873332T3 (da) Discodermolidforbindelser samt farmaceutiske sammensætninger indeholdende dem til cancerterapi
Kim et al. A case of mucosa-associated lymphoid tissue lymphoma of the sigmoid colon presenting as a semipedunculated polyp
NO924025D0 (no) Antistoffkonjugater for behandling av neoplastisk sykdom
SE7706526L (sv) Forfarande for framstellnilng av 3-(3-karboxi-4-hydroxifenyl)-4,5-dihydro-2-fenylbens/e/indol och dermed beslektade verdefulla mellanforeningar
WO1991019725A3 (en) Heterocyclic anthracyclione and anthracycline analogs
DE69942637D1 (de) Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs
ATE397673T1 (de) Verstärktes krebs-gen wip1
Mackman et al. The second look operation for carcinoma of the colon after administration of 5-fluorouracil
MX9100290A (es) Compuestos de antraceno utiles farmaceuticamente.
SHIRAISHI et al. A CASE OF SIMULTANEOUS MALE BREAST AND ESOPHAGEAL CANCER
RU92016483A (ru) Аналоги гетероциклических антрациклинов и антрациклионов
JPS5651414A (en) Antibiotic substance neplanocin preparation
CA2045593A1 (en) Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
SADAHIRO et al. A CLINICOPATHOLOGICAL STUDY OF CASES WITH CANCER OF UNKNOWN ORIGIN ANALYSIS OF CELLULAR PROTEINS IN PRIMARY AND METASTATIC CANCEROUS TISSUE
Silverstein et al. A Prognostic Index for Breast Ductal Carcinoma in Situ (DCIS)
ATE49965T1 (de) Verwendung von 2-beta-d-ribofuranosylthiazol-4carboxamiden zur herstellung von medikamenten zur behandlung von krebsartigen tumoren.
SU1129921A1 (ru) Штамм дизэмбриогенетической опухоли кишечника, используемый для изучения патогенеза и лечения злокачественного роста
SE8700850L (sv) Metod och anordning att stralbehandla cancertumorer med applicerande av stralningen utanfor kroppen, pa cancertumorens symetriska antimateria, som uppstar bakom spegel
DE3177155D1 (de) Verwendung von 2-beta-d-ribofuranosylthiazol-4-carboxamiden zur herstellung von medikamenten zur behandlung von krebsartigen tumoren.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7706526-6

Effective date: 19910131

Format of ref document f/p: F